
Boehringer Ingelheim is the world’s largest private pharmaceutical company. Let’s work together to co-create the next generation of breakthroughs in human and animal health.
Our human pharma partnering interests: Cardio-renal-metabolic diseases, Eye health, Immunology & Respiratory diseases; Neuroscience, Oncology, Technologies.
Our animal health partnering interests: Bacterial, viral & parasitic diseases; Cardio-renal-metabolic & obesity; CNS; Immunology & Inflammation; Oncology, Oral health; Pain & mobility; Technologies; Digital Science.
Scott DeWire
Corporate Sr. Vice President & Global Head of Business Development, Human Pharma
"BIO is an important opportunity for us to build new partnerships, and our team is looking forward to hearing your ideas. If you share our mission to transform lives for generations and you have an innovative new concept, please come by our partnering space and tell us all about it."
Log in to BIO Partnering™ to send us a meeting request.

Human Pharma Business Development & Licensing
Director, Business Development & Strategic Partnering, Oncology
Director, Business Development & Strategic Partnering, Oncology
Fei Shen
Head of Business Development & Licensing USA, and Global Head of Inflammation Business Development
Global Head of Business Development & Licensing, Cardio-Renal-Metabolic Diseases
Alessandra Barazza
Director, Business Development & Licensing, Technologies
Global Head of Business Development & Licensing, Eye Health
Director, Strategic Partnering, Immunology
Global Head of Business Development & Licensing, Mental Health & Neuroscience
June Hahn
Head of Business Development & Licensing, Korea
Director, Business Development & Licensing, NBE Technologies & Immunology
Bernd Nosse
Global Head Business Development & Licensing, Technologies
Animal Health Business Development & Licensing
Hervé Poulet
Senior Director, Strategic Partnering, Animal Health
Veljko Nikolin
Director, Strategic Partnering, Animal Health



